Magazine article from our research archive:

DSM expects 3Q loss from restructuring.(News: Europe)

DSM IS expecting to report a loss of 70 million [euro] to 90 million [euro] ($80 million to $100 million) in the third quarter mainly over the cost of restructuring its pharmaceutical intermediates and elastomers businesses.

A total of 102 million [euro], consisting of 59 million [euro] in writedowns and 43 million [euro] in other provisions, is being charged to the quarterly accounts. There will also be a 15 million [euro] nonrecurring charge resulting from an explosion at a glyoxylic acid plant at Linz, Austria, which remains closed.

Around 600 jobs will be lost following the closure and mothballing of intermediates and elastomers plants in the US and in the ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!